Ectopic expression of neurotrophic peptide derived from saposin C increases proliferation and upregulates androgen receptor expression and transcriptional activity in human prostate cancer cells

Asian Journal of Andrology

Volumn 9, Issue 5, 2007, Pages 601-609

  Ding, Yan ^a   Yuan, Hui Qing ^a   Kong, Feng ^a   Hu, Xiao Yan ^a   Ren, Kai ^a   Cai, Jie ^a   Wang, Xiao Ling ^a   Young, Charles Y F ^b  

^a SHANDONG UNIVERSITY   (China)

^b MAYO CLINIC   (United States)

Author keywords

Androgen receptor; Neurotrophic peptide; Prostate carcinoma cell lines; SaposinC

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; NEUROTROPHIC FACTOR; SAPOSIN C; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN LNCAP; CHIMERA; CONTROLLED STUDY; DNA VECTOR; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NITROBLUE TETRAZOLIUM TEST; PROSTATE CANCER; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

CELL DIVISION; CELL LINE, TUMOR; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; KINETICS; MALE; NERVE GROWTH FACTORS; PANCREATIC NEOPLASMS; RECEPTORS, ANDROGEN; RESTRICTION MAPPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SAPOSINS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 34548425649     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1111/j.1745-7262.2007.00328.x     Document Type: Article

References (19)

1. Taplin ME, Balk SP. Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence. J Cell Biochem 2004; 91: 483-90.
2. Suzuki H, Ito H. Role of androgen receptor in prostate cancer. Asian J Androl 1999; 1: 81-5.
3. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001; 1: 34-45.
4. Jenster G. Ligand-independent activation of the androgen receptor in prostate cancer by growth factors and cytokines. J Pathol 2000; 191: 227-8.
5. Culig Z. Androgen receptor cross-talk with cell signalling pathways. Growth Factors 2004; 22: 179-84.
6. Kishimoto Y, Hiraiwa M, O'Brien JS. Saposins: Structure, function, distribution, and molecular genetics. J Lipid Res 1992; 33: 1255-67.
7. O'Brien JS, Carson GS, Seo HC, Hiraiwa M, Kishimoto Y. Identification of prosaposin as a neurotrophic factor. Proc Natl Acad Sci U S A 1994; 91: 9593-6.
8. Campana WM, Hiraiwa M, O'Brien JS. Prosaptide activates the MAPK pathway by a G-protein-dependent mechanism essential for enhanced sulfatide synthesis by Schwann cells. FASEB J 1998; 12: 307-14.
9. Hiraiwa M, Taylor EM, Campana WM, Darin SJ, O'Brien JS. Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides. Proc Natl Acad Sci U S A 1997; 94: 4778-81.
10. Campana WM, Hiraiwa M, Addison KC, O'Brien JS. Induction of MAPK phosphorylation by prosaposin and prosaptide in PC12 cells. Biochem Biophys Res Commun 1996; 229: 706-12.
11. Morales CR, Badran H. Prosaposin ablation inactivates the MAPK and AKT signaling pathways and interferes with the development of the prostate gland. Asian J Androl 2003; 5: 57-63.
12. Koochekpour S, Zhang YJ, Beroukhim R, Hsieh CL, Hofer MD, Zhau HE, et al. Amplification and overexpression of prosaposin in prostate cancer. Genes Chromosomes Cancer 2005; 44: 351-64.
13. Lee TJ, Sartor O, Luftig RB, Koochekpour S. Saposin C promotes survival and prevents apoptosis via PI3K/Akt-depen-dent pathway in prostate cancer cells. Mol Cancer 2004; 3: 31.
14. Koochekpour S, Sartor O, Lee TJ, Zieske A, Patten D Y, Hiraiwa M, et al. Prosaptide TX14A stimulates growth, migration, and invasion and activates the Raf-MEK-ERK-RSK-Elk-1 signaling pathway in prostate cancer cells. Prostate 2004; 61: 114-23.
15. Koochekpour S, Sartor O, Hiraiwa M, Lee TJ, Rayford W, Remmel N, et al. Saposin C stimulates growth and invasion, activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells. Asian J Androl 2005; 7: 147-58.
16. Koochekpour S, Lee TJ, Wang R, Culig Z, Delorme N, Caffey S, et al. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Prostate 2007; 67: 178-89.
17. Taylor EM, Otero DA, Banks WA, O'Brien JS. Designing stable blood-brain barrier-permeable prosaptide peptides for treatment of central nervous system neurodegeneration. J Pharmacol Exp Ther 2000; 293: 403-9.
18. Yuan H, Gong A, Young CY. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the an-drogen receptor in human prostate cancer cells. Carcinogenesis 2005; 26: 793-801.
19. Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res 2002; 62: 1008-13.